"Footprint-Free" human induced pluripotent stem cell-derived astrocytes for in vivo cell-based therapy

Stem Cells and Development

Volumn 23, Issue 21, 2014, Pages 2626-2636

  Mormone, Elisabetta ^a   D'sousa, Sunita ^a   Alexeeva, Vera ^a   Bederson, Maria M ^a   Germano, Isabelle M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL HOMING; CELL SELECTION; CELL THERAPY; FOOTPRINT FREE HUMAN INDUCED PLURIPOTENT CELL DERIVED ASTROCYTE; GLIOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; TERATOMA; ADULT; ANIMAL; BIOLOGICAL THERAPY; CELL LINE; CYTOLOGY; DRUG SCREENING; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NUDE MOUSE; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSPLANTATION; TUMOR CELL LINE;

ADULT; ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; OCTAMER TRANSCRIPTION FACTOR-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84913612749     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0151     Document Type: Article

References (60)

1. Bergstrom T and K Forsberg-Nilsson. (2012). Neural stem cells: Brain building blocks and beyond. Ups J Med Sci 117:132-142.
2. Emdad L, SL DSouza, HP Kothari, ZA Qadeer and IM Germano. (2012). Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. Stem Cells Dev 21:404-410.
3. Hu BY, JP Weick and J Yu. (2010). Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A 107:4335-4340.
4. Shaltouki A, J Peng, Q Liu, MS Rao and X Zenget. (2013). Efficient generation of astrocytes from human pluripotent stem cells in defined conditions. Stem Cells 31:941-952.
5. Okano H, M Nakamura, K Yoshida, Y Okada, O Tsuji, S Nori, E Ikeda, S Yamanaka and K Miura. (2013). Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 112:523-533.
6. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
7. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
8. Yu J, K Hu, K Smuga-Otto, S Tian, R Stewart, II Slukvin and JA Thomson. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801.
9. Stadtfeld M, M Nagaya, J Utikal, G Weir and K Hochedlinger. (2008). Induced pluripotent stem cells generated without viral integration. Science 322:945-953.
10. Tucker BA, KR Anfinson, RF Mullins, EM Stone and MJ Young. (2013). Use of synthetic xeno-free culture substrate for inducing pluripotent stem cells induction and retinal differentiation. Stem Cells Transl Med 2:16-24.
11. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
12. Zhou H, S Wu, JY Joo, S Zhu, DW Han, T Lin, S Trauger, G Bien, S Yao, et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4:381-412.
13. Macarthur CC, A Fontes, N Ravinder, D Kuninger, J Kaur, M Bailey, A Taliana, MC Vemuri and PT Lieu. (2012). Generation of human-induced pluripotent stem cells by a non integrating RNA Sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int 2012:564-612.
14. Fusaki N, H Ban, A Nishiyama, K Saeki and M Hasegawa. (2009). Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85:348-362.
15. Warren L, PD Manos, T Ahfeldt, YH Loh, H Li, F Lau, W Ebina, PK Mandal, ZD Smith, et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7:618-630.
16. Warren L, Y Ni, J Wang and X Guo. (2012). Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Sci Rep 2:657-664.
17. Mandal PK and DJ Rossi. (2013). Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat Protoc 8:568-582.
18. Okita K, M Nakagawa, H Hyenjong, T Ichisaka and S Yamanaka. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953.
19. Benveniste R and IM Germano. (2003). Evaluation of factors predicting accurate resection of high-grade gliomas using frameless image-guided stereotactic guidance. Neurosurg Focus 14:1-4.
20. Ostrom QT, H Gittleman, P Farah, A Ondracek, Y Chen, Y Wolinski, NE Stroup, C Kruchko and JS Barnholtz-Sloan. (2013). CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 15 Suppl 2:ii1-ii56.
21. Germano IM, M Ito, K Cho, T Hoshino, RL Davis and CB Wilson. (1989). Correlation of histopathological features and proliferative potential of individual gliomas. J Neurosurg 70:701-706.
22. Germano IM, J Fable, SH Gultekin and A Silvers. (2003). Adenovirus/herpes simplex-Thymidine kinase/gancyclovir complex: Preliminary results of a phase I trial in patients with recurrent malignant gliomas. J Neurooncol 65:279-289.
23. Germano IM, M Uzzaman, RJ Benveniste, M Zaurova and G Keller. (2006). Apoptosis in human glioblastoma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand. J Neurosurg 105:88-95.
24. Kanu OO, A Mehta, C Di, N Lin, K Bortoff, DD Bigner, H Yan and DC Adamson. (2009). Glioblastoma multiforme: A review of therapeutic targets. Expert Opin Ther Targets 13:701-718.
25. Schiffer D, MT Giordana, IM Germano and A Mauro. (1986). Anaplasia and heterogeneity of GFAP expression in gliomas. Tumori 72:163-170.
26. Stupp R, W Mason, M van den Bent, M Weller, B Fisher, MJ Taphoorn, K Belanger, AA Brandes, C Marosi, et al. (2005). Radiotherpay plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996.
27. Adamson C, OO Kanu, AI Mehta, C Di, N Li, AK Mattox and DD Bigner. (2009). Glioblastoma multiforme: A review of where we have been and where we are going. Expert Opin Investig Drugs 18:1061-1083.
28. Germano IM, L Emdad, ZA Qadeer, E Binello and M Uzzman. (2010). Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas. Cancer Gene Ther 17: 664-674.
29. Zhang SC, M Wernig, ID Duncan, O Brstle and JA Thomson. (2001). In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19:1129-1133.
30. Chambers SM, CA Fasano, EP Papapetrou, M Tomishima, M Sadelain and L Studer. (2009). Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27:275-280.
31. Dietrich J, et al. (2002). Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia 40:65-77.
32. Seidenfaden R, A Desoeuvre, A Bosio, I Virard and H Cremer. (2006). Glial conversion of SVZderived committed neuronal precursors after ectopic grafting into the adult brain. Mol Cell Neurosci 32:187-198.
33. Heese O, A Disko, D Zirkel, M Westphal and K Lamszus. (2005). Neural stem cell migration toward gliomas in vitro. Neuro Oncol 7:476-484.
34. Nakamizo A, F Marini, T Amano, A Khan, M Studeny, J Gumin, J Chen, S Hentschel, G Vecil, et al. (2005). Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307-3318.
35. Poon RY. (2002). PKH fluorescent cell linker dyes. In: In Living Color: Flow Cytometry and Cell Sorting Protocols. Diamond RA, S De Maggio, eds. Springer, New York. pp 302-352.
36. Bin Z, S Xiaolei, L Xiulan, Y Qiang, L Yanjun, Z Yang, L Bing and M Xinlong. (2013). Imprroved preparation of a cellular nerve scaffold and application of PKH26 fluorescent labeling combined with in vivo fluorescent imaging system in nerve tissue engineering. Neurosci Lett 556:52-57.
37. Franklin KBJ and G Paxinos. (2010). The Mouse Brain in Stereotaxic Coordinates, Second Edition. Academic Press, New York.
38. Mooney CZ and RD Duval. (1993). Bootstrapping: A Nonparametric Approach to Statistical Inference. Sage, Newbury Park, CA.
39. Tabernero A, A Orfao and JM Medina. (1996). Astrocyte differentiation in primary culture followed by flow cytometry. Neurosci Res 24:131-138.
40. Krencik R and SC Zhang. (2011). Directed differentiation of functional astroglial subtypes from human pluripotent stem cells. Nat Protoc 6:1710-1717.
41. Benveniste RJ, G Keller and I Germano. (2005). Embryonic stem cell-derived astrocytes expressing drug-inducible transgenes: Differentiation and transplantion into the mouse brain. J Neurosurg 103:115-123.
42. Uzzaman M, G Keller and IM Germano. (2009). In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas. Neuro Oncol 11:102-108.
43. Cao J, X Li, C Zhang, H Yu and T Zhao. (2013). Cells derived from iPSC can be immunogenic-yes or no? Protein Cell 5:1-3.
44. Karnoub AE,ABDash, AP Vo,ASullivan,MWBrooks,GW Bell, AL Richardson, K Polyak, R Tubo and RA Weinberg. (2007). Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557-563.
45. Akimoto K, K Kimura,MNagano, S Takano, G Toa Salazar, T Yamashita and O Ohneda. (2013). Umbilical cord bloodderived mesenchymal stem cells inhibit, but adipose tissuederived mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells Dev 22:1370-1386.
46. Yuan T, W Liao, NH Feng, YL Lou, X Niu, AJ Zhang, Y Wang and ZF Deng. (2013). Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurological function in a rat model of middle cerebral artery occlusion. Stem Cell Res Ther 4:73-83.
47. Chung HC, RC Lin, GJ Logan, IE Alexander, PS Sachdev and KS Sidhu. (2012). Human induced pluripotent stem cell derived under feeder-free conditions display unique cell cycle and DNA replication gene profiles. Stem Cells Dev 21:206-216.
48. Ramirez MA, E Pericuesta, R Fernandez-Gonzalez, B Pintado and A Gutierrez-Adan. (2007). Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies. Int J Dev Biol 51:397-407.
49. Fu W, SJ Wang, GD Zhou, W Liu, Y Cao and WJ Zhang. (2012). Residual undifferentiated cells during differentiation of induced pluripotent stem cells in vitro and in vivo. Stem Cells Dev 21:521-529.
50. Liu Z, Y Tang, S Lu, J Zhou, Z Du, C Duan, Z Li and C Wang. (2013). The tumorigensis of iPSC and their differentiated derivates. J Cell Mol Med 17:782-791.
51. Erdo F, C Buhrle, J Blunk, M Hoehn, Y Xia, B Fleischmann, M Focking, E Kustermann, E Kolossov, et al. (2003). Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 23:780-785.
52. Wakitani S, K Takaoka, T Hattori, N Miyazawa, T Iwanaga, S Takeda, TK Watanabe and A Tanigami. (2003). Embryonic stem cells injected into the mouse knee joint form teratomas and subsequently destroy the joint. Rheumatology 42:162-165.
53. Wang L, Y Li, X Chen, J Chen, SC Gautam, Y Xu and M Chopp. (2002). MCP-1, MIP-1,IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 7:113-117.
54. Zhang H, L Vutskits, MS Pepper and JZ Kiss. (2003). VEGF is a chemoattractant for FGF-2-stimulated neural progenitors. J Cell Biol 163:1375-1384.
55. Shinojima N, A Hossain, T Takezaki, J Fueyo, J Gumin, F Gao, F Nwajei, FC Marini, M Andreeff, J Kuratsu and FF Lang. (2013). TGF-b mediates homing of bone marrowderived human mesenchymal stem cells to glioma stem cells. Cancer Res 73:2333-2344.
56. Buffo A, C Rolando and S Ceruti. (2010). Astrocytes in the damaged brain: Molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol 79:77-89.
57. Dahl D, H Mansourour and A Bignami. (1991). Astrocytes colonize dorsal root ganglia transplanted unto rat brain. Brain Res Bull 27:169-173.
58. Kang W and JM Hebert. (2011). Signaling pathways in reactive astrocytes, a genetic perspective. Mol Neurobiol 43:147-154.
59. Ho KW, WS Lambert and DJ Calkins. (2014). Activation of the TRPV1 cation channel contributes to stress-induced astrocyte migration. Glia [Epub ahead of print]; DOI: 10.1002/glia.22691.
60. Germano IM and E Binello. (2009). Gene therapy as an adjuvant treatment for malignant gliomas: From bench to bedside. J Neurooncol 93:79-87.